Medicare Enrolled
Dr. Khaled Khalaf, M.D.
Cardiovascular Disease · Humble, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khalaf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khalaf? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khalaf
Dr. Khaled Khalaf is a cardiovascular disease in Humble, TX, with 13 years in practice. Based on federal Medicare data, Dr. Khalaf performed 2,908 Medicare services across 1,991 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khalaf received a total of $147,925 from 78 pharmaceutical and/or device companies across 1274 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khalaf is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 36% volume in TX$ $147,925 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,908
Medicare services
Top 36% in TX for cardiovascular disease
1,991
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~224 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 397 | $103 | $283 |
| Electrocardiogram (EKG), 12-lead | 274 | $11 | $44 |
| Regadenoson injection (Lexiscan) for heart stress test | 256 | $42 | $285 |
| Blood draw (venipuncture) | 203 | $8 | $10 |
| Magnesium level test | 145 | $7 | $21 |
| Comprehensive metabolic blood panel | 142 | $10 | $36 |
| Complete blood count (CBC) with differential | 134 | $8 | $24 |
| Echocardiogram, transthoracic | 123 | $135 | $528 |
| Lipid panel (cholesterol and triglycerides) | 105 | $13 | $42 |
| Office visit, established patient, complex (40-54 min) | 86 | $129 | $382 |
| Thyroid stimulating hormone (TSH) test | 85 | $16 | $56 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 84 | $9 | $30 |
| Prothrombin time test (blood clotting) | 71 | $4 | $16 |
| Natriuretic peptide (heart and blood vessel protein) level | 69 | $38 | $105 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 66 | $56 | $184 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 65 | $613 | $895 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 63 | $1,977 | $5,980 |
| Hospital follow-up visit, high complexity | 62 | $97 | $277 |
| Chest X-ray, 2 views | 50 | $26 | $85 |
| Coagulation assessment blood test, plasma or whole blood | 42 | $6 | $19 |
| New patient office visit, complex (60-74 min) | 39 | $153 | $543 |
| New patient office visit (45-59 min) | 35 | $120 | $435 |
| Hemoglobin A1c test (diabetes monitoring) | 34 | $10 | $30 |
| Ultrasonic guidance for blood vessel access | 32 | $32 | $74 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | $41 | $97 |
| Cardiac catheterization | 28 | $167 | $1,573 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 27 | $1,377 | $4,901 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 26 | $777 | $2,000 |
| Office visit, established patient (20-29 min) | 26 | $61 | $196 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $48 | $229 |
| Basic metabolic blood panel | 20 | $8 | $28 |
| Initial hospital admission, high complexity | 20 | $142 | $536 |
| Coronary stent placement | 18 | $458 | $1,561 |
| Blood creatinine level | 13 | $5 | $16 |
| Urea nitrogen level to assess kidney function, quantitative | 13 | $4 | $13 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
15.1% medium
79.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$147,925
Total received (2018-2024)
Avg $21,132/year across 7 years
Top 4% in TX for cardiovascular disease
78
Companies
1,274
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57,799 (39.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$40,695 (27.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$39,930 (27.0%)
Other
Charitable contributions, space rental, and other categories
$9,502 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$45,454
2023$30,443
2022$27,061
2021$14,227
2020$11,122
2019$11,434
2018$8,185
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$32,109
CVRx, Inc.
$24,403
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13,848
Abbott Laboratories
$12,085
AngioDynamics, Inc.
$9,719
Inari Medical, Inc.
$7,424
AtriCure, Inc.
$7,152
Medtronic Vascular, Inc.
$6,823
Janssen Pharmaceuticals, Inc
$6,611
Veryan Medical Incorporated
$3,722
ABIOMED
$2,446
Novartis Pharmaceuticals Corporation
$2,319
Impulse Dynamics (USA) Inc.
$1,943
ATRICURE, INC.
$1,888
Boston Scientific Corporation
$1,222
Bard Peripheral Vascular, Inc.
$1,076
CARDIVA MEDICAL, INC.
$815
Cardiovascular Systems Inc.
$750
PFIZER INC.
$720
Amgen Inc.
$712
AstraZeneca Pharmaceuticals LP
$699
BOSTON SCIENTIFIC CORPORATION
$674
E.R. Squibb & Sons, L.L.C.
$605
BIOTRONIK INC.
$597
Tactile Systems Technology Inc
$520
ASAHI INTECC USA, INC.
$489
Merck Sharp & Dohme LLC
$476
Endologix LLC
$436
BARD PERIPHERAL VASCULAR, INC.
$421
ShockWave Medical, Inc
$347
Esperion Therapeutics, Inc.
$343
Philips Electronics North America Corporation
$295
Novo Nordisk Inc
$274
HeartFlow, Inc.
$268
Shockwave Medical, Inc
$246
Amarin Pharma Inc.
$244
Teleflex LLC
$243
Penumbra, Inc.
$235
Silk Road Medical, Inc.
$209
Recor Medical Inc
$172
Chiesi USA, Inc.
$161
Astellas Pharma US Inc
$151
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Opsens Inc.
$135
Resmed Corp
$131
Microtransponder, Inc.
$125
Kowa Pharmaceuticals America, Inc.
$125
Edwards Lifesciences Corporation
$107
CHIESI USA, INC.
$106
Itamar Medical Inc
$101
Canon Medical Systems USA, Inc.
$99
CardioFocus, Inc.
$98
SANOFI-AVENTIS U.S. LLC
$98
ZOLL Circulation Inc
$87
Biocompatibles, Inc.
$85
CORDIS US CORP.
$71
Bolton Medical Inc
$66
Merck Sharp & Dohme Corporation
$45
Inspire Medical Systems, Inc.
$44
Surmodics, Inc.
$41
Regeneron Pharmaceuticals, Inc.
$38
Arrow International, Inc.
$32
Biohaven Pharmaceutical Holding Company Ltd.
$27
Actelion Pharmaceuticals US, Inc.
$21
Medicure Pharma Inc.
$21
Avinger Inc.
$21
Allergan Inc.
$20
Tandem Diabetes Care, Inc.
$17
Siemens Medical Solutions USA, Inc.
$15
CashFlow Solutions, LLC
$15
LeMaitre Vascular, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$14
Becton, Dickinson and Company
$13
EKOS Corporation
$12
Regeneron Healthcare Solutions, Inc.
$12
Cook Medical LLC
$11
iRhythm Technologies, Inc.
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$6
Top 3 companies account for 47.6% of total payments
Associated products mentioned in payments ›
(9520) IGT Devices Und · (9556) IVC Filter Removal · ABRE · ABSOLUTE PRO · ADVISOR · AGILIS HISPRO · AIR 11 · ALPHAVAC · AMPLATZER · ARCTIC FRONT ADVANCE · ASAHI PTCA Guide Wire · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AVVIGO Guidance System · Accent Pacemaker · AirMini · Allure Quadra RF CRT Pacemaker · Alto Abdominal Stent Graft System · Amplia MRI · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BELSOMRA · BRILINTA · BYSTOLIC · Barostim Neo System · BioMimics · BioMimics 3D Vascular Stent System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · COMET · CONFIRM RX · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Catheter - GuideLiner · Catheter - Pronto · Catheter - Turnpike · ClosureFast · ClosureRFS · Confirm Rx · Connectivity and Remote care · Cook Medical Catheters · CorPath Imaging System · CoreValve Evolut · Corlanor · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · Diamondback Peripheral · Dragonfly OCT · Durata Defibrillation ICD Lead · EKOSONIC · ELIQUIS · EMBLEM · ENDURANT IIS · ENROUTE Transcarotid Neuroprotection System · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · ESPRIT · Ensite Cardiac Mapping System · FARXIGA · FFR LINK · FFRct · FLEXITOUCH · FLOWTRIEVER CATHETER · Flexitouch Plus · GALLANT · GENERAL STENTS · GENERAL - ATHERECTOMY · GENERAL - STRUCTURAL HEART · GENERAL - THROMBECTOMY · GENERAL STENTS · GUIDELINER · GUIDEZILLA · General - Stents · HawkOne · HeartWare HVAD · ICDs · IGT D Peripheral · IGT Devices Und · IGT_D Peripheral · ILAB · IN.PACT Admiral · INSPIRE · Impella · Indigo · Inpefa · JARDIANCE · JETI · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LIFESTAR · LIFESTENT · LIFESTREAM · LUTONIX · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · MERLIN@HOME · MITRACLIP · MULTAQ · NAVITOR · NEXLETOL · NEXLIZET · NURTEC ODT · OPSUMIT · OPTICROSS · OPTIMIZER · OTHER · Optimizer · Optimizer Smart System · OptoWire · Orsiro Mission · Ozempic · PANTHERIS · PARADISE RENAL DENERVATION SYSTEM · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · PERIPHERAL VASCULAR · PET-CT SCANNER · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESTO · Pacemakers · Peripheral Orbital Atherectomy System · Pounce Thrombectomy · Pounce Venous Thrombectomy System · Prostar XL surgical system · Quadra Assura CRT Defibrillator · RADIAL 360 · RESOLUTE ONYX · RESTOREFLO · RHYTHMIA · ROTABLATOR · Relay Grafts · Repatha · Resolute · Rotarex · RotarexS 6 F x 135 cm · S · SAMURAI · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · STEGLATRO · SUPERA · SYNERGY · SYNERGY ABLATION SYSTEM · Saxenda · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Supera peripheral stent system · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Temperature Management System · TherOx DS2 Console · ULTRAVERSE · VALEO · VARITHENA · VENASEAL · VENOVO · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Vascular Closure Device · Vascular Lithotripsy · VenaSeal · Venovo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · WatchPAT · XARELTO · XIENCE ALPINE · XIENCE SIERRA · XIENCE SKYPOINT · XIENCE XPEDITION · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Xience V coronary stent system · ZIO Patch · ZYPITAMAG · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (39%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in TX.
Equivalent to $5,087 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
350
Per 100K population
7.4
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN NORTHEAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khalaf is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 4%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khalaf experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khalaf performed 397 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khalaf receive payments from pharmaceutical companies?
Yes. Dr. Khalaf received a total of $147,925 from 78 companies across 1,274 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khalaf's costs compare to other cardiovascular diseases in Humble?
Dr. Khalaf's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khalaf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Humble
Browse cardiovascular diseases in Humble ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
CVRx, Inc. Payments to Doctors
See all physicians who received payments from CVRx, Inc..
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology